4021-75-4

Basic information

• Product Name: 2,3-dibromobutan-1-ol
• Synonyms: 2,3-Dibromobutanol; Butanol, 2,3-dibromo-
• CAS NO: 4021-75-4
• Molecular Formula: C₄H₈Br₂O
• Molecular Weight: 231.9137
• Mol File: 4021-75-4.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 249.6°C at 760 mmHg
• Flash Point: 104.8°C
• Density: 1.945g/cm³
• Vapor Pressure: 0.00363mmHg at 25°C
• Refractive Index: 1.541
• CAS DataBase Reference: 2,3-dibromobutan-1-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-dibromobutan-1-ol(4021-75-4)
• EPA Substance Registry System: 2,3-dibromobutan-1-ol(4021-75-4)

Safety Data

• Hazardous Substances Data: 4021-75-4(Hazardous Substances Data)

Usage

General Description

2,3-dibromobutan-1-ol is a chemical compound with the molecular formula C4H8Br2O. It is a colorless, odorless liquid that is used in various chemical reactions and processes. The compound is derived from butan-1-ol, with bromine atoms attached to the second and third carbon atoms. It is primarily used as an intermediate in the synthesis of other organic compounds and is also used as a reagent in organic chemistry reactions. 2,3-dibromobutan-1-ol is a versatile compound with a variety of potential uses in the field of organic chemistry. It is important to handle and store this chemical compound with caution due to its potential hazards.

Upstream product

• 504-61-0 (E)-but-2-enol 
• 123-73-9 trans-Crotonaldehyde 
• 6117-91-5 (E/Z)-2-buten-1-ol 
• 4088-60-2 cis-2-buten-1-ol 
• 4021-75-4 (2R*,3R*)-2,3-dibromobutan-1-ol 

Downstream Products

• 600-30-6 erythro-2,3-dibromobutanoic acid 
• 632-05-3 1,2,3-tribromobutane 
• 52467-65-9 (Z)-2-bromobut-2-en-1-ol 
• 6117-91-5 (E/Z)-2-buten-1-ol 
• 4021-75-4 (–)-(2S,3S)-2,3-dibromobutan-1-ol 
• 4021-75-4 threo-2,3-Dibrombutan-1-ol 

Relevant articles and documents

COMPOUNDS USEFUL IN INHIBITING KETOHEXOKINASE AND METHODS OF MAKING AND USING THE SAME

The present invention relates to compounds that can act as inhibitors of ketohexokinase (KHK) and that can be useful in the treatment of diseases and/or disorders associated with KHK. In some embodiments, the present invention relates to compounds and com

Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose

Increased fructose consumption and its subsequent metabolism have been implicated in metabolic disorders such as nonalcoholic fatty liver disease and steatohepatitis (NAFLD/NASH) and insulin resistance. Ketohexokinase (KHK) converts fructose to fructose-1

SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS

Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.